130 related articles for article (PubMed ID: 197928)
1. Cyclic adenosine 3',5'-monophosphate and prostacyclin inhibit membrane phospholipase activity in platelets.
Lapetina EG; Schmitges CJ; Chandrabose K; Cuatrecases P
Biochem Biophys Res Commun; 1977 Jun; 76(3):828-35. PubMed ID: 197928
[No Abstract] [Full Text] [Related]
2. Regulation of phospholipase activity in platelets.
Lapetina EG; Schmitges CJ; Chandrabose K; Cuatrecasas P
Adv Prostaglandin Thromboxane Res; 1978; 3():127-35. PubMed ID: 207172
[No Abstract] [Full Text] [Related]
3. The activation by Ca2+ of platelet phospholipase A2. Effects of dibutyryl cyclic adenosine monophosphate and 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate.
Rittenhouse-Simmons S; Deykin D
Biochim Biophys Acta; 1978 Nov; 543(4):409-22. PubMed ID: 214141
[TBL] [Abstract][Full Text] [Related]
4. Cyclic AMP and platelet prostaglandin synthesis.
Gerrard JM; Peller JD; Krick TP; White JG
Prostaglandins; 1977 Jul; 14(1):39-50. PubMed ID: 197570
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.
Hidaka H; Hayashi H; Kohri H; Kimura Y; Hosokawa T; Igawa T; Saitoh Y
J Pharmacol Exp Ther; 1979 Oct; 211(1):26-30. PubMed ID: 226672
[No Abstract] [Full Text] [Related]
6. HL 725, an extremely potent inhibitor of platelet phosphodiesterase and induced platelet aggregation in vitro.
Ruppert D; Weithmann KU
Life Sci; 1982 Nov; 31(19):2037-43. PubMed ID: 6294426
[TBL] [Abstract][Full Text] [Related]
7. Nicergoline, an anti-aggregating agent which inhibits release of arachidonic acid from human platelet phospholipids.
Lagarde M; Guichardant M; Ghazi I; Dechavanne M
Prostaglandins; 1980 Apr; 19(4):551-7. PubMed ID: 7384555
[TBL] [Abstract][Full Text] [Related]
8. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
[TBL] [Abstract][Full Text] [Related]
9. Some biochemical activities of 10,10-difluoro-13-dehydroprostacyclin, a chemically stable analog of prostacyclin, in human blood platelets.
Harris DN; Phillips MB; Michel IM; Goldenberg HJ; Haslanger MF; Antonaccio MJ; Fried J
Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):387-99. PubMed ID: 6275567
[No Abstract] [Full Text] [Related]
10. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties.
Needleman P; Raz A; Minkes MS; Ferrendelli JA; Sprecher H
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):944-8. PubMed ID: 218223
[TBL] [Abstract][Full Text] [Related]
11. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
Haslam RJ; Rosson GM
Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
[No Abstract] [Full Text] [Related]
12. Differential effects of calmodulin antagonists on phospholipases A2 and C in thrombin-stimulated platelets.
Walenga RW; Opas EE; Feinstein MB
J Biol Chem; 1981 Dec; 256(23):12523-8. PubMed ID: 6795206
[No Abstract] [Full Text] [Related]
13. Phospholipase A2 and platelet aggregation.
Blackwell GJ
Adv Prostaglandin Thromboxane Res; 1978; 3():137-42. PubMed ID: 655004
[No Abstract] [Full Text] [Related]
14. Inhibition of platelet phospholipase-A2 as a mechanism for the anti-aggregating effect of linoleic acid.
Vallee E; Gougat J; Ageron M
Agents Actions; 1980 Apr; 10(1 Pt 2):57-62. PubMed ID: 7386309
[TBL] [Abstract][Full Text] [Related]
15. Interference of bromophenacyl bromide with platelet phospholipase A2 activity induced by thrombin and by the ionophore A23187.
Vargaftig BB; Fouque F; Chignard M
Thromb Res; 1980 Jan 1-15; 17(1-2):91-102. PubMed ID: 6246654
[No Abstract] [Full Text] [Related]
16. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
Salzman EW
Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP metabolism in cholesterol-rich platelets.
Sinha AK; Shattil SJ; Colman RW
J Biol Chem; 1977 May; 252(10):3310-4. PubMed ID: 193833
[No Abstract] [Full Text] [Related]
18. Local anesthetics, chlorpromazine and propranolol inhibit stimulus-activation of phospholipase A2 in human platelets.
Vanderhoek JY; Feinstein MB
Mol Pharmacol; 1979 Jul; 16(1):171-80. PubMed ID: 384205
[No Abstract] [Full Text] [Related]
19. Effect of diamide (azodicarboxylic acid-bis-dimethylamide) on arachidonic acid release from human blood platelet phospholipids.
Lösche W; Michel E; Thielmann K; Till U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):769-73. PubMed ID: 6083952
[TBL] [Abstract][Full Text] [Related]
20. The role of phospholipids in platelet function.
Morin RJ
Ann Clin Lab Sci; 1980; 10(6):463-73. PubMed ID: 6255856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
